ADVOCATING FOR AUSTRALIAN CHILDREN LIVING WITH VISION IMPAIRMENT
Australian Childhood Vision Impairment Register
With
Dr Susan Silveira
Chief Investigator
Australian Childhood Vision Impairment Register, NextSense &
Program Director
Master of Disability Studies (Macquarie University), NextSense
AUSTRALIAN HEALTH JOURNAL SEGMENT
Filmed in Sydney | June 2025
The Australian Childhood Vision Impairment Register (ACVIR), the first of its kind in Australia, captures uniquely Australian data which is used to improve services for children with vision impairment. The data is also available to researchers who work in the area of eye disease and disorders of vision.
Currently in Australia, we don’t know how many Australian children have vision impairment.
This makes it hard to plan for the services these children need, or to argue for research into preventing conditions which cause vision impairment.
NextSense Institute, in partnership with key Australian service providers, corporate donors, government departments and health professionals, has undertaken a major research project to develop and maintain an Australia-wide record of children with vision impairment.
This project is called the Australian Childhood Vision Impairment Register.
Australian Health Journal spoke with Dr Susan Silveira, Chief Investigator of the Register.
The Register collects accurate information on children who have been diagnosed by an ophthalmologist (eye doctor) with vision impairment.. This information is used to establish the number of children with vision impairment, the causes and level of vision impairment and any additional disabilities and health conditions these children have.
The Parent or guardian of a child, aged 0-18 years, who has been diagnosed by an ophthalmologist with vision impairment, are invited to join the Australian Childhood Vision Impairment Register.
The Australian Childhood Vision Impairment Register (ACVIR) is sponsored by NextSense with support from Guide Dogs, Vision Australia, low vision service providers and families of children with vision loss.
Source: Written by AUDIENCED sourced from NextSense website
-
National Cancer Plan activates Australian Comprehensive Cancer Network
The landscape of cancer care in Australia is set to transform with the Australian Government launch in May 2024 of the Australian Comprehensive Cancer Network (ACCN) at the Innovations Showcase event, hosted by Cancer Australia in Sydney, Australia.
The ACCN is a nationally integrated system of cancer care, aimed at enhancing patient experiences and outcomes through coordinated and equitable access, by linking to comprehensive cancer services across Australia. Anchored by Comprehensive Cancer Centres (CCCs), the ACCN strives to deliver evidence-driven prevention, diagnosis, treatment, and support to all Australians affected by cancer.
-
Lasers in dental treatment without needles and drills
In 2017, Dr. Omar Zuaiter and Alaa Habeb launched Dentroid, a dental technology startup with a mission to make dentistry a kinder and friendlier experience for patients and dentists using photonics (using laser technology) and robotics, as alternatives to needles, drills and sprays. The vision for the startup is to have dentistry adopt laser technology, addressing the root causes of dental pain & anxiety, and create a pain-free dental experience.
-
Developing the nation’s first Health and Medical Research Strategy
Professor Steve Wesselingh serves as the CEO of NHMRC, having initially trained as an infectious diseases doctor. His career includes prominent roles such as Head of the Infectious Diseases Unit at the Alfred Hospital, Director of the Burnett, Dean of Medicine at Monash University, and the inaugural Director of SAHMRI. Under his leadership, NHMRC plays a critical role in funding health and medical research, allocating approximately a billion dollars annually to investigator-led projects, clinical trials, and various strategic initiatives. NHMRC also collaborates internationally with organisations such as the MRC and the EU, and manages grant allocation for the MRFF, which distributes $650 million each year.
